Prostate-specific membrane antigen antibody–drug conjugate (PSMA ADC): A phase I trial in taxane-refractory prostate cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 4650-4650 ◽  
Author(s):  
D. P. Petrylak ◽  
P. W. Kantoff ◽  
R. C. Frank ◽  
N. D. Shore ◽  
Y. Rotshteyn ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Prostate Specific Membrane Antigen ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antigen Antibody ◽  
Specific Membrane ◽  
Antibody Drug

Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer

The Prostate ◽  
2019 ◽  
Vol 79 (6) ◽  
pp. 604-613 ◽  
Author(s):  
Daniel P. Petrylak ◽  
Philip Kantoff ◽  
Nicholas J. Vogelzang ◽  
Anthony Mega ◽  
Mark T. Fleming ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase 1 ◽  
Prostate Specific Membrane Antigen ◽  
Antibody Drug Conjugate ◽  
Phase 1 Study ◽  
Drug Conjugate ◽  
Specific Membrane ◽  
Antibody Drug
Sign in / Sign up

Export Citation Format

Share Document